The Jerusalem Post
SEPTEMBER 4, 2021 19:37
A study from the University of Arizona discovered that an enzyme with a key role in severe inflammation may be a vital mechanism in COVID-19 severity and could provide a new target for medicine development.
The researchers collaborated with Stony Brook University and Wake Forest School of Medicine to analyze blood samples from two COVID-19 patients and discovered that the circulation of the sPLA2-11A enzyme may be an important method in predicting which patients would die of COVID-19.